Alex S. Bennett, PhD
NYU School of Global Public Health - Research Associate Professor
NYU School of Global Public Health - Director, Opioid Overdose Prevention Program
PhD, Applied History and Public Policy, Carnegie Mellon University
MPA, Public Policy Research and Analysis, University of Pittsburgh
BA/MA, History, University of Florida
Research Interests
Overdose prevention, Naloxone, Veterans health, Mixed-methods research, Opioids, Drug use, HIV/HCV prevention, Community-engaged research
Alex Bennett specializes in ethnographic, historical and mixed-methods research to address drug overdose, infectious disease and other drug-related harm among a broad cross-section of at-risk populations including military veterans, people who use and/or inject drugs, and those managing various forms of biopsychosocial pain. He has been involved in substance use and overdose prevention both in academic and community settings conducting research, needs assessment, program development, service delivery, and evaluation work.  In his research, Dr. Bennett has focused on a wide range of psychoactives in both historical and contemporary contexts. Over the past decade, he has been working with military veterans, as partners and community health outreach specialists, to develop harm reduction programs tailored to veterans who use opioids to prevent overdose and blood-borne viral infection while simultaneously helping them access low-threshold healthcare and supportive services.
Principal Investigator, Evaluation of a Community-Based Education, Navigation, and Support (CENS) Intervention to Reduce Opioid-Related Harms Among Military Veterans. Active
Principal Investigator, Overdose Risk Management and Compensation in the Era of Naloxone. Active
Principal Investigator, Opioid Misuse and Overdose Risk Patterns Among Recent Veterans. Completed
Principal Investigator, Technology to Increase Naloxone Uptake Among Opioid Users Who Initially Decline. Completed


Bennett AS, Townsend T, Elliott L (2022).
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
International Journal of Drug Policy, 101, 103554. doi: 10.1016/j.drugpo.2021.103554. PMCID: PMC8632599.

Ibitoye M, Bennett AS, Bugaghis M, Chernick LS, Des Jarlais DC, Aronson ID (2021).
Provider perspectives on barriers to routine HIV testing of adolescent and young adult patients in emergency department settings
Behavioral Medicine [Epub 2021 Dec 29]. doi: 10.1080/08964289.2021.2020207.

Bennett AS, Elliott L (2021).
Naloxone’s role in the national opioid crisis – past struggles, current efforts, and future opportunities
Translational Research, 234, 43-57. doi: 10.1016/j.trsl.2021.03.001. PMCID: PMC8327685.

Elliott L, Crasta D, Khan M, Roth A, Green T, Kolodny A, Bennett AS (2021).
Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2)
Drug and Alcohol Dependence, 223, 108721. doi: 10.1016/j.drugalcdep.2021.108721. PMCID: PMC8113089.

Bennett AS, Freeman R, Des Jarlais DC, Aronson ID (2020).
Reasons people who use opioids do not accept or carry no-cost naloxone: Qualitative interview study
JMIR Formative Research, 4 (12), e22411. doi: 10.2196/22411. PMCID: PMC7787889.


Bennett AS, Bell A, Tomedi L, Hulsey EG, Kral AH (2011).
Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania
Journal of Urban Health, 88 (6), 1020-1030. doi: 10.1007/s11524-011-9600-7. PMCID: PMC3232410.

Dr. Bennett's Research Gate Profile